Project Grant R01AI129812

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,303,086 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore to conduct the "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)" research project. The study aims to evaluate the long-term epidemiological impact of two malaria prevention interventions - seasonal malaria chemoprevention (SMC) and the...

This Cooperative Agreement award of $800,470 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to comprehend the complex interplay between malaria epidemiology and vector biology in Southeast Asia, with a particular emphasis on the dynamics of human and zoonotic malaria transmission. The research program, executed across Thailand and Malaysia, consists of two interdependent projects:...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS Federal Grant Program (CFDA 93.067) provides $3,710,204 in funding to Humana People To People Congo (Hpp-Congo) to implement the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project in Kinshasa, Democratic Republic of the Congo. The project aims to support comprehensive HIV/AIDS prevention, testing, treatment, and care services in the Kinshasa region, in alignment with the...

This $102,600 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is supporting research to compare sampling methods for the invasive Anopheles stephensi mosquito and other native malaria vectors in Ghana. The primary objectives are to evaluate surveillance tools, determine the extent of spread, and characterize the bionomics of the Anopheles stephensi mosquito in Ghana. The research...

This $133,664 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to characterize the network of vector-host-virus interactions within the Laguna Mar Chiquita (LMC) and Bañados del Río Dulce (BDRD) wetlands in Argentina. The key objectives are to: Identify host bloodmeals in wetland mosquitoes to elucidate the potential viral flow between resident and migratory birds. Analyze...

This $606,815 Cooperative Agreement awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to engineer paratransgenic bacterial strains that can interfere with the ability of mosquitoes to transmit malaria parasites. Specifically, the project will: Engineer Asaia bogorensis bacterial strains that contain no antibiotic resistance genes, are highly resistant to horizontal transfer, and secrete effector proteins to optimize...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,204 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the London School of Hygiene and Tropical Medicine (LSHTM) to develop the knowledge, tools, and strategies needed to support malaria intervention and control programs in India. The key products and services to be delivered under this 5-year award include: Monitoring the changing epidemiology of malaria in Odisha,...

This $128,640 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to effectively link molecular informatics and network analytics to reduce malaria in the Northern Peruvian Amazon. The key objectives are to: 1) Quantify human mobility patterns and identify networks of villages to understand the effects on malaria transmission; and 2) Link community network data with genomic...

The Association de Sante Familiale (ASF) and PATH were awarded a $6,749,031 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Global AIDS Federal Grant Program (CFDA 93.067) for the "USHINDI Project" in the Democratic Republic of the Congo (DRC). The project aims to enhance access to comprehensive HIV prevention, care, and treatment services in seven health zones in Haut-Katanga Province to achieve epidemic control. Key objectives include...

This federal Project Grant award for $246,521.00, awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports the development of a workforce training program to build capacity in West Africa for pathogen surveillance and outbreak response. The key elements of the award include: Establishing a training program at the University of Science, Techniques and Technologies of Bamako (USTTB) in Mali to teach best practices for...